Novelion Therapeutics Overview

  • Year Founded
  • 1981

Year Founded

  • Status
  • Out of Business

  • Employees
  • 109

Employees

  • Latest Deal Type
  • Liquidation

  • Financing Rounds
  • 7

  • Investments
  • 8

Novelion Therapeutics General Information

Description

Developer of rare disease drugs based in Vancouver, Canada. The company specializes in developing pharmaceutical drugs catering to people suffering from diseases like lipodystrophy, Leber congenital amaurosis, and retinitis pigmentosa.

Contact Information

Formerly Known As
Qlt Phototherapeutics
Ownership Status
Out of Business
Financing Status
Corporation
Corporate Office
  • 1800 - 510 West Georgia Street
  • Vancouver, British Columbia V6B 0M3
  • Canada
+1 (877)
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Drug Discovery
Vertical(s)
Corporate Office
  • 1800 - 510 West Georgia Street
  • Vancouver, British Columbia V6B 0M3
  • Canada
+1 (877)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novelion Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novelion Therapeutics‘s full profile, request access.

Request a free trial

Novelion Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of rare disease drugs based in Vancouver, Canada. The company specializes in developing pharmaceutical drugs c
Pharmaceuticals
Vancouver, Canada
109 As of 2018

Cleveland, OH
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Novelion Therapeutics Competitors (96)

One of Novelion Therapeutics’s 96 competitors is Abeona Therapeutics, a Corporation company based in Cleveland, OH.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Abeona Therapeutics Corporation Cleveland, OH
Genentech Formerly VC-backed South San Francisco, CA
Santhera Pharmaceuticals Holding Formerly VC-backed Pratteln, Switzerland
Verona Pharma Corporate Backed or Acquired London, United Kingdom
Merck & Co. Corporation Rahway, NJ
You’re viewing 5 of 96 competitors. Get the full list »

Novelion Therapeutics Patents

Novelion Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2015023902-A3 Improving visual function associated with impaired dark adaptation and/or impaired low luminance vision Inactive 14-Aug-2013
WO-2015023902-A2 Therapeutic regimens and methods for improving visual function in visual disorders associated with impaired dark adaptation and/or impaired low luminance vision Inactive 14-Aug-2013
US-20140094484-A1 Sustained delivery formulations of rapamycin compounds Inactive 02-Oct-2012
WO-2013164671-A1 Drug delivery system and methods of treating open angle glaucoma and ocular hypertension Inactive 03-May-2012
US-20130253411-A1 Photodynamic therapy laser Active 21-Mar-2012 A61F9/00821
To view Novelion Therapeutics’s complete patent history, request access »

Novelion Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novelion Therapeutics Investments & Acquisitions (8)

Novelion Therapeutics’s most recent deal was a Merger/Acquisition with Aegerion Pharmaceuticals for . The deal was made on 29-Nov-2016.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Aegerion Pharmaceuticals 29-Nov-2016 Merger/Acquisition Drug Discovery
Aralez Pharmaceuticals 05-Feb-2016 PIPE Pharmaceuticals
Othera Pharmaceuticals (OT-730 drug) 30-Dec-2009 Corporate Asset Purchase Buildings and Property
ForSight NewCo 19-Oct-2007 Merger/Acquisition Drug Delivery
ForSight Vision2 18-Oct-2007 Merger/Acquisition Drug Delivery
You’re viewing 5 of 8 investments and acquisitions. Get the full list »

Novelion Therapeutics Exits (3)

Novelion Therapeutics’s most recent exit was on 29-Nov-2016 from Aegerion Pharmaceuticals. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Aegerion Pharmaceuticals 29-Nov-2016 Completed
Aralez Pharmaceuticals 05-Feb-2016 Completed
  • 4 buyers
Tribute Pharmaceuticals 04-Jun-2004 Early Stage VC Completed
  • 3 buyers
To view Novelion Therapeutics’s complete exits history, request access »

Novelion Therapeutics FAQs

  • When was Novelion Therapeutics founded?

    Novelion Therapeutics was founded in 1981.

  • Where is Novelion Therapeutics headquartered?

    Novelion Therapeutics is headquartered in Vancouver, Canada.

  • What is the size of Novelion Therapeutics?

    Novelion Therapeutics has 109 total employees.

  • What industry is Novelion Therapeutics in?

    Novelion Therapeutics’s primary industry is Pharmaceuticals.

  • Is Novelion Therapeutics a private or public company?

    Novelion Therapeutics is a Private company.

  • What is Novelion Therapeutics’s current revenue?

    The current revenue for Novelion Therapeutics is .

  • How much funding has Novelion Therapeutics raised over time?

    Novelion Therapeutics has raised $22M.

  • Who are Novelion Therapeutics’s competitors?

    Abeona Therapeutics, Genentech, Santhera Pharmaceuticals Holding, Verona Pharma, and Merck & Co. are some of the 96 competitors of Novelion Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process